These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37152994)

  • 41. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
    Gao F; Liu H; Meng X; Liu J; Wang J; Yu J; Liu X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Golchehre Z; Chavoshzadeh Z; He J; Zhang H; Wang X
    Br J Haematol; 2023 Sep; 202(6):1151-1164. PubMed ID: 37455019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphoma.
    Herrera AF; Kim HT; Kong KA; Faham M; Sun H; Sohani AR; Alyea EP; Carlton VE; Chen YB; Cutler CS; Ho VT; Koreth J; Kotwaliwale C; Nikiforow S; Ritz J; Rodig SJ; Soiffer RJ; Antin JH; Armand P
    Br J Haematol; 2016 Dec; 175(5):841-850. PubMed ID: 27711974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
    Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
    Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients.
    Francaviglia I; Magliacane G; Lazzari C; Grassini G; Brunetto E; Dal Cin E; Girlando S; Medicina D; Smart CE; Bulotta A; Gregorc V; Pecciarini L; Doglioni C; Cangi MG
    Lung Cancer; 2019 Aug; 134():225-232. PubMed ID: 31319985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.
    Diefenbach RJ; Lee JH; Stewart A; Menzies AM; Carlino MS; Saw RPM; Stretch JR; Long GV; Scolyer RA; Rizos H
    Front Oncol; 2022; 12():820510. PubMed ID: 35494035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer.
    Eyck BM; Jansen MP; Noordman BJ; Atmodimedjo PN; van der Wilk BJ; Martens JW; Helmijr JA; Beaufort CM; Mostert B; Doukas M; Wijnhoven BP; Lagarde SM; van Lanschot JJB; Dinjens WN
    J Pathol; 2023 Jan; 259(1):35-45. PubMed ID: 36196486
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML.
    Ruan M; Liu L; Qi B; Chen X; Chang L; Zhang A; Liu F; Wang S; Liu X; Chen X; Zhang L; Guo Y; Zou Y; Zhang Y; Chen Y; Liu L; Cao S; Lou F; Wang C; Zhu X
    Front Oncol; 2021; 11():666470. PubMed ID: 34422630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating tumor DNA predicts response in Chinese patients with relapsed or refractory classical hodgkin lymphoma treated with sintilimab.
    Shi Y; Su H; Song Y; Jiang W; Sun X; Qian W; Zhang W; Gao Y; Jin Z; Zhou J; Jin C; Zou L; Qiu L; Li W; Yang J; Hou M; Xiong Y; Zhou H; Du X; Wang X; Peng B
    EBioMedicine; 2020 Apr; 54():102731. PubMed ID: 32304999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.
    Louissaint A; Schafernak KT; Geyer JT; Kovach AE; Ghandi M; Gratzinger D; Roth CG; Paxton CN; Kim S; Namgyal C; Morin R; Morgan EA; Neuberg DS; South ST; Harris MH; Hasserjian RP; Hochberg EP; Garraway LA; Harris NL; Weinstock DM
    Blood; 2016 Aug; 128(8):1093-100. PubMed ID: 27325104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36/TNFRSF14 abnormalities, and STAT6 mutations.
    Siddiqi IN; Friedman J; Barry-Holson KQ; Ma C; Thodima V; Kang I; Padmanabhan R; Dias LM; Kelly KR; Brynes RK; Kamalakaran S; Houldsworth J
    Mod Pathol; 2016 Jun; 29(6):570-81. PubMed ID: 26965583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mutation profiling of circulating tumor DNA identifies distinct mutation patterns in non-Hodgkin lymphoma.
    Fu H; Shen J; Zhou H; Zhang F; Li H; Ma Z; Huang W; Chen L; Chen Y; Liu T
    Eur J Haematol; 2022 Apr; 108(4):298-309. PubMed ID: 34997652
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus infection is an independent prognostic factor in follicular lymphoma.
    Shimono J; Miyoshi H; Kato T; Sugio T; Miyawaki K; Kamimura T; Miyagishima T; Eto T; Imaizumi Y; Kato K; Nagafuji K; Akashi K; Seto M; Teshima T; Ohshima K
    Oncotarget; 2018 Jan; 9(2):1717-1725. PubMed ID: 29416725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.
    Herbreteau G; Langlais A; Greillier L; Audigier-Valette C; Uwer L; Hureaux J; Moro-Sibilot D; Guisier F; Carmier D; Madelaine J; Otto J; Souquet PJ; Gounant V; Merle P; Molinier O; Renault A; Rabeau A; Morin F; Denis MG; Pujol JL
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33261056
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circulating tumor DNA assisting lymphoma genetic feature profiling and identification.
    Wang H; Wang Z; Zhu S; Li Z; Yang H; Sun P; Zhu M; Zhao X; Shen L; Ou Q; Yang H; Li ZM
    Ann Hematol; 2024 Oct; 103(10):4135-4144. PubMed ID: 39012515
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival.
    Ye S; Zhou S; Wu Y; Pei X; Jiang W; Shi W; Yang W; Zhou X; Shan B; Yang H
    Ann Med; 2023 Dec; 55(1):2218104. PubMed ID: 37272300
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma.
    Zhang L; Zhang R; Wang J; Chen Y; Qiao C; Shi Q; Jin Y; Shen X; Li J; Chen L
    Clin Epigenetics; 2022 Jul; 14(1):93. PubMed ID: 35870987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms.
    Kalmbach S; Grau M; Zapukhlyak M; Leich E; Jurinovic V; Hoster E; Staiger AM; Kurz KS; Weigert O; Gaitzsch E; Passerini V; Engelhard M; Herfarth K; Beiske K; Micci F; Möller P; Bernd HW; Feller AC; Klapper W; Stein H; Hansmann ML; Hartmann S; Dreyling M; Holte H; Lenz G; Rosenwald A; Ott G; Horn H;
    Leukemia; 2023 Oct; 37(10):2058-2065. PubMed ID: 37563306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas.
    Kim SJ; Kim YJ; Yoon SE; Ryu KJ; Park B; Park D; Cho D; Kim HY; Cho J; Ko YH; Park WY; Kim WS
    Cancer Res Treat; 2023 Jan; 55(1):291-303. PubMed ID: 35240014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV.
    Los-de Vries GT; Stevens WBC; van Dijk E; Langois-Jacques C; Clear AJ; Stathi P; Roemer MGM; Mendeville M; Hijmering NJ; Sander B; Rosenwald A; Calaminici M; Hoster E; Hiddemann W; Gaulard P; Salles G; Horn H; Klapper W; Xerri L; Burton C; Tooze RM; Smith AG; Buske C; Scott DW; Natkunam Y; Advani R; Sehn LH; Raemaekers J; Gribben J; Kimby E; Kersten MJ; Maucort-Boulch D; Ylstra B; de Jong D
    Blood Adv; 2022 Sep; 6(18):5482-5493. PubMed ID: 35816682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.
    Mozas P; López C; Grau M; Nadeu F; Clot G; Valle S; Kulis M; Navarro A; Ramis-Zaldivar JE; González-Farré B; Rivas-Delgado A; Rivero A; Frigola G; Balagué O; Giné E; Delgado J; Villamor N; Matutes E; Magnano L; García-Sanz R; Huet S; Russell RB; Campo E; López-Guillermo A; Beà S
    Hematol Oncol; 2023 Oct; 41(4):631-643. PubMed ID: 36994552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.